PacBio appoints Chris Gibson (Recursion co-founder) to board; effective March 3, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Board expanded to 10; Gibson appointed Class I director with term expiring at 2026 annual meeting.
Gibson also named to PacBio's Science and Technology Committee.
He is co-founder and Chairman of Recursion (RXRX), an AI-driven biotech with a drug discovery platform.
No related party transactions between Gibson and PacBio; standard indemnification agreement to be entered.
Company cites Gibson's experience in AI, automation, and high-dimensional biology as strategic for HiFi sequencing data tools.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.